Brand check

Is Dart tablet banned in India?

Last checked 21 September 2026

Dart. Status: SC interim relief · on sale.

Dart tablet is on sale in India as of 19 Sep 2026: its 2018 ban is on hold under the same Supreme Court interim order of February 2019 that covered Saridon and Piriton.

Classification
Ban stayed by a court
Decided by
CDSCO / Ministry of Health and Family Welfare; Supreme Court of India
Reference
S.O. notification of 7 Sep 2018, 328-FDC wave; Supreme Court interim order, Feb 2019
Latest action
21 February 2019
Last checked
21 September 2026

Photo: Pills Medicine by Michal Jarmoluk (CC0). All photo credits.

Best source we have: a news reportTier 3: news report

Medical Dialogues: FDC ban: Supreme Court relief to Saridon, Piriton and Dart

CDSCO / Ministry of Health and Family Welfare; Supreme Court of India · S.O. notification of 7 Sep 2018, 328-FDC wave; Supreme Court interim order, Feb 2019

Our team has checked this record against the published reports, last on 21 September 2026. The government order itself is not published online, or we have not found it yet, so we link the best public report. If you have the order, send it to us and we will link it instead.

View original source

Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

Below: Blacklisted's explanationWe explain what has been reported. The report above is the best source we hold.

Key facts

Governing authority
CDSCO, MoHFW; Supreme Court of India
Ban notification
7 Sep 2018 (328-FDC wave; S.O. number)
Court relief
Supreme Court, February 2019, with Saridon and Piriton
Manufacturer
Juggat Pharma
Current position
On sale, sub judice

Dart is a headache and pain tablet from Juggat Pharma, sold mainly in southern India, and it shares its legal story with Saridon.

It was among the 328 fixed-dose combinations prohibited by the Health Ministry on 7 September 2018 after the Drugs Technical Advisory Board reviewed the list sent back by the Supreme Court. Juggat Pharma challenged the order. In February 2019 the Supreme Court granted interim relief to Dart together with Saridon and Piriton expectorant, letting the products stay on sale until the petitions are decided.

That interim order is still the operative position as of 19 September 2026. The 2018 notification has not been withdrawn, and the final hearing has not been reported, so the correct description is "banned on paper, on sale by court order".

Two details need checking before this page is treated as final. The content plan does not record which S.O. number under the 2018 wave applies to Dart, and the product's composition should be confirmed from the current label rather than from older listings. Searchers in Kannada and Tamil regularly ask why the tablet was banned; the answer is the same as for Saridon, a DTAB finding of no therapeutic justification for the combination, which the courts have yet to rule on.

What this means for you

It can still be sold

Pharmacies may dispense Dart while the interim order stands.

The case is not over

A final Supreme Court decision could restore the ban. Check back or ask your pharmacist if you rely on it.

This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.

Batches flagged in CDSCO alerts

Products whose name matches this brand or molecule in CDSCO monthly NSQ alerts. A flagged batch is a single batch; the company's response, where reported, is noted on the page above.

Product Batch Manufacturer Reason declared NSQ Tested by Alert
Paracetamol, Propyphenazone and Caffeine Tablets (Dart Analgesic Tablets) 1802012Mfg 2018-02 · Exp 2021-01 Juggat Pharma 47/1Karnataka DisintegrationDisintegration RDTL GuwahatiState lab Mar 2020

Official sources and primary records